Support By : Li-lab
PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
---|---|---|---|---|---|
Adipocytokine signaling pathway | R-HSA-168638 | map04920 | enoxacin | 6234 | drug-path |
GnRH signaling pathway | R-HSA-168638 | map04912 | enoxacin | 6234 | drug-path |
Vascular smooth muscle contraction | R-HSA-445355 | map04270 | enoxacin | 6234 | drug-path |
Olfactory transduction | R-HSA-9751605 | map04740 | enoxacin | 6234 | drug-path |
Cell adhesion molecules (CAMs) | R-HSA-1031690 | 0 | enoxacin | 6234 | drug-path |
Systemic lupus erythematosus | R-HSA-977105 | map05322 | enoxacin | 6234 | drug-path |
Pancreatic cancer | R-HSA-9700206 | map05212 | enoxacin | 6234 | drug-path |
Prostate cancer | R-HSA-2990872 | map05215 | enoxacin | 6234 | drug-path |
Graft-versus-host disease | R-HSA-1643685 | map05332 | bephenium hydroxynaphthoate | 54678490 | drug-path |
Fc epsilon RI signaling pathway | R-HSA-2454202 | map04664 | bephenium hydroxynaphthoate | 54678490 | drug-path |
Asthma | R-HSA-444620 | map05310 | bephenium hydroxynaphthoate | 54678490 | drug-path |
Parkinson's disease | R-HSA-1643685 | 0 | bephenium hydroxynaphthoate | 54678490 | drug-path |
Allograft rejection | R-HSA-9679028 | map05330 | bephenium hydroxynaphthoate | 54678490 | drug-path |
Type I diabetes mellitus | R-HSA-5683209 | map04940 | bephenium hydroxynaphthoate | 54678490 | drug-path |
Homologous recombination | R-HSA-5685942 | map03440 | bephenium hydroxynaphthoate | 54678490 | drug-path |
Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | bephenium hydroxynaphthoate | 54678490 | drug-path |
Olfactory transduction | R-HSA-9751605 | map04740 | bephenium hydroxynaphthoate | 54678490 | drug-path |
Systemic lupus erythematosus | R-HSA-977105 | map05322 | bephenium hydroxynaphthoate | 54678490 | drug-path |
Apoptosis | R-HSA-109581 | map04210 | bephenium hydroxynaphthoate | 54678490 | drug-path |
Cytokine-cytokine receptor interaction | R-HSA-6788467 | map04060 | bephenium hydroxynaphthoate | 54678490 | drug-path |